Details for New Drug Application (NDA): 050577
✉ Email this page to a colleague
NDA 050577 describes ZANOSAR, which is a drug marketed by Teva Pharms Usa and is included in one NDA. It is available from one supplier. Additional details are available on the ZANOSAR profile page.
The generic ingredient in ZANOSAR is streptozocin. One supplier is listed for this compound. Additional details are available on the streptozocin profile page.
The generic ingredient in ZANOSAR is streptozocin. One supplier is listed for this compound. Additional details are available on the streptozocin profile page.
Summary for 050577
| Tradename: | ZANOSAR |
| Applicant: | Teva Pharms Usa |
| Ingredient: | streptozocin |
| Patents: | 0 |
Pharmacology for NDA: 050577
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 050577
Suppliers and Packaging for NDA: 050577
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZANOSAR | streptozocin | INJECTABLE;INJECTION | 050577 | NDA | Teva Parenteral Medicines, Inc. | 0703-4636 | 0703-4636-01 | 10 mL in 1 VIAL (0703-4636-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/VIAL | ||||
| Approval Date: | May 7, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
